High bacterial coinfection rates and associated mortality among hospitalized older adults with laboratory-confirmed respiratory syncytial virus infection
Yu-Chang Fu , Ting-wei Lai , Yu-Hua Su , Yu-Chao Lin , Chih-Yen Tu , Chieh-Lung Chen , Po-Ren Hsueh
{"title":"High bacterial coinfection rates and associated mortality among hospitalized older adults with laboratory-confirmed respiratory syncytial virus infection","authors":"Yu-Chang Fu , Ting-wei Lai , Yu-Hua Su , Yu-Chao Lin , Chih-Yen Tu , Chieh-Lung Chen , Po-Ren Hsueh","doi":"10.1016/j.jmii.2025.03.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Emerging evidence highlights that respiratory syncytial virus (RSV) poses a significant risk to older adults. However, detailed clinical data on elderly patients hospitalized with RSV remains limited. This study investigates the clinical characteristics and outcomes of older adults (aged ≥50 years) hospitalized with RSV infection.</div></div><div><h3>Methods</h3><div>This retrospective cohort study included hospitalized patients aged ≥50 years with respiratory symptoms and laboratory-confirmed RSV infection at China Medical University Hospital between January 1, 2011, and December 31, 2023. Data on demographic characteristics and clinical presentations were collected. RSV infection-related outcomes were analyzed across various subgroups.</div></div><div><h3>Results</h3><div>This study included 36 patients, with the most prevalent comorbidities being diabetes mellitus (47.2 %), immunocompromised status (36.1 %), and chronic lung disease (30.6 %). Pneumonia was identified in 72.2 % of patients, while 41.7 % required invasive mechanical ventilation, and the hospital mortality rate was 33.3 %. Non-survivors had higher rates of comorbidities, particularly chronic lung disease (66.7 % vs. 12.5 %, <em>p</em> = 0.002), higher disease severity, elevated procalcitonin levels, and were more likely to develop septic shock and acute respiratory distress syndrome. A bacterial coinfection rate of 33.3 % was observed, with patients experiencing pneumonia or bacterial coinfection showing poorer outcomes. Moreover, patients with chronic lung disease exhibited significantly worse day-28 survival (log-rank <em>p</em> < 0.001).</div></div><div><h3>Conclusions</h3><div>The disease burden of RSV in older adults is amplified by comorbidities such as chronic lung disease, with pneumonia and bacterial coinfections further worsening outcomes. Our findings highlight the need for a more comprehensive understanding and effective preventive strategies to protect this vulnerable population.</div></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"58 4","pages":"Pages 422-428"},"PeriodicalIF":3.7000,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Microbiology Immunology and Infection","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1684118225000672","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Emerging evidence highlights that respiratory syncytial virus (RSV) poses a significant risk to older adults. However, detailed clinical data on elderly patients hospitalized with RSV remains limited. This study investigates the clinical characteristics and outcomes of older adults (aged ≥50 years) hospitalized with RSV infection.
Methods
This retrospective cohort study included hospitalized patients aged ≥50 years with respiratory symptoms and laboratory-confirmed RSV infection at China Medical University Hospital between January 1, 2011, and December 31, 2023. Data on demographic characteristics and clinical presentations were collected. RSV infection-related outcomes were analyzed across various subgroups.
Results
This study included 36 patients, with the most prevalent comorbidities being diabetes mellitus (47.2 %), immunocompromised status (36.1 %), and chronic lung disease (30.6 %). Pneumonia was identified in 72.2 % of patients, while 41.7 % required invasive mechanical ventilation, and the hospital mortality rate was 33.3 %. Non-survivors had higher rates of comorbidities, particularly chronic lung disease (66.7 % vs. 12.5 %, p = 0.002), higher disease severity, elevated procalcitonin levels, and were more likely to develop septic shock and acute respiratory distress syndrome. A bacterial coinfection rate of 33.3 % was observed, with patients experiencing pneumonia or bacterial coinfection showing poorer outcomes. Moreover, patients with chronic lung disease exhibited significantly worse day-28 survival (log-rank p < 0.001).
Conclusions
The disease burden of RSV in older adults is amplified by comorbidities such as chronic lung disease, with pneumonia and bacterial coinfections further worsening outcomes. Our findings highlight the need for a more comprehensive understanding and effective preventive strategies to protect this vulnerable population.
背景:新出现的证据强调呼吸道合胞病毒(RSV)对老年人构成重大风险。然而,关于因呼吸道合胞病毒住院的老年患者的详细临床数据仍然有限。本研究探讨了老年人(≥50岁)因呼吸道合胞病毒感染住院的临床特征和结局。方法:本回顾性队列研究纳入2011年1月1日至2023年12月31日在中国医科大学附属医院住院的年龄≥50岁且伴有呼吸道症状和实验室确诊的呼吸道合胞病毒感染的患者。收集了人口学特征和临床表现的数据。分析不同亚组的RSV感染相关结果。结果:该研究包括36例患者,最常见的合并症是糖尿病(47.2%)、免疫功能低下(36.1%)和慢性肺部疾病(30.6%)。72.2%的患者确诊为肺炎,41.7%的患者需要有创机械通气,医院死亡率为33.3%。非幸存者的合并症发生率更高,特别是慢性肺病(66.7% vs. 12.5%, p = 0.002),疾病严重程度更高,降钙素原水平升高,更有可能发生感染性休克和急性呼吸窘迫综合征。观察到细菌合并感染率为33.3%,出现肺炎或细菌合并感染的患者预后较差。此外,慢性肺病患者的28天生存率明显较差(logrank p)。结论:慢性肺病等合并症放大了老年人RSV的疾病负担,肺炎和细菌共感染进一步恶化了预后。我们的研究结果强调需要更全面的了解和有效的预防策略来保护这一弱势群体。
期刊介绍:
Journal of Microbiology Immunology and Infection is an open access journal, committed to disseminating information on the latest trends and advances in microbiology, immunology, infectious diseases and parasitology. Article types considered include perspectives, review articles, original articles, brief reports and correspondence.
With the aim of promoting effective and accurate scientific information, an expert panel of referees constitutes the backbone of the peer-review process in evaluating the quality and content of manuscripts submitted for publication.